The Beijing Intellectual Property Court recently issued the first-ever decision in a dispute between a brand-name and a generic drug company under China's newly-created patent linkage regime. Fang Qi and Danlei Wu of Fangda Partners examine the decision and its implications
Intellectual Property
- June 09, 2022
Technical IP cases are handled by IP courts and intermediate people's courts
June 02, 2022Danlei Wu of Fangda Partners shines a light on the Supreme People's Court's latest IP annual report, and shows how the SPC is leading the way in developing China's litigation landscape
May 20, 2022Chinese court imposes stringent requirements on NFT marketplaces to monitor copyright compliance; New rules on dissemination of false and price-sensitive information and pricing; Heightened burden on live-streaming platforms to protect minors
May 17, 2022China allows for international design filings with the Hague System
May 13, 2022Beijing approves Baidu, Pony.ai to operate robotaxis without supervisor in driver's seat; U.S government blacklists China again over lax IP protection and enforcement; BlackRock launches private pension product, first foreign asset manager to do so
May 04, 2022Interpretation on Several Issues Concerning the Application of the «PRC Anti-Unfair Competition Law»
SPC issues the unfair competition interpretation addressing illegitimate online activities
April 29, 2022VIE structure is clarified and recognized in human genetic resources projects
April 11, 2022CSRC proposes an update to confidentiality rules for overseas listings; Shanghai rolls out 21 economic relief measures for firms amid lockdown; and social credit to be further developed, more integration in capital markets
April 06, 2022Shanghai issues its first IP compliance guidelines
March 11, 2022





